Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?The Motley Fool • 07/21/24
AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 07/09/24
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024Business Wire • 05/28/24
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/07/24
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesBusiness Wire • 05/01/24
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/30/24
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024Business Wire • 04/08/24
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024Business Wire • 03/19/24
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological ConditionsBusiness Wire • 03/11/24
AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/21/24